RESEARCHER PROFILE
Carmen Ili
← Back to Universidad de La Frontera
C
Universidad de La Frontera
Carmen Ili works in Epigenetics and DNA Methylation, Cervical Cancer and HPV Research, Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Head and Neck Cancer Studies. Recorded institutional associations include Universidad de La Frontera, Millennium Institute on Immunology and Immunotherapy, Biomedical Research Consortium-Chile (Chile).
138Publications
1,521Citations
21H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds
2010 · 199 citationsNID2 and HOXA9 Promoter Hypermethylation as Biomarkers for Prevention and Early Detection in Oral Cavity Squamous Cell Carcinoma Tissues and Saliva
2011 · 147 citationsHigh-resolution microbiome profiling uncoversFusobacterium nucleatum,Lactobacillus gasseri/johnsonii, andLactobacillus vaginalisassociated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation
2017 · 97 citationsA reliable Epstein-Barr Virus classification based on phylogenomic and population analyses
2019 · 88 citationsmiR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.
2014 · 76 citationsThe ERK/MAPK pathway is overexpressed and activated in gallbladder cancer
2017 · 58 citationsDifferential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity
2014 · 52 citationsEarly detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies
2017 · 44 citationsNovel Methylation Biomarkers for Colorectal Cancer Prognosis
2021 · 41 citationsImmunohistochemical Expression of Phospho-mTOR Is Associated With Poor Prognosis in Patients With Gallbladder Adenocarcinoma
2013 · 39 citationsGenome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population
2013 · 36 citationsImmunohistochemical Expression of Vascular Endothelial Growth Factor A in Advanced Gallbladder Carcinoma
2013 · 35 citationsLandscape of Genome-Wide DNA Methylation of Colorectal Cancer Metastasis
2020 · 31 citationsLong Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma
2023 · 31 citationsRole of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
2020 · 30 citationsLong non-coding RNAs in gastric cancer: mechanisms and potential applications
2016 · 28 citationsFunctional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
2019 · 27 citationsGlobal and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile
2014 · 25 citationsEvaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I
2014 · 25 citationsEpigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance
2024 · 25 citationsThe Role of Clock Genes in Fibrinolysis Regulation: Circadian Disturbance and Its Effect on Fibrinolytic Activity
2020 · 22 citationsFunctional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
2020 · 20 citationsCellular FLICE-like Inhibitory Protein Long Form (c-FLIPL) Overexpression is Related to Cervical Cancer Progression
2013 · 19 citationsGenotyping of human papillomavirus in cervical intraepithelial neoplasia in a high‐risk population
2011 · 19 citationsReprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
2016 · 19 citations
